 |
Previous Article | Next Article 
Volume 16, Number 14,
Issue of July 15, 1996
pp. 4449-4456
Copyright ©1996 Society for Neuroscience
Double Transduction with GTP Cyclohydrolase I and Tyrosine
Hydroxylase Is Necessary for Spontaneous Synthesis of
L-DOPA by Primary Fibroblasts
Received Dec. 13, 1995; revised March 26, 1996; accepted April 17, 1996.
Craig Bencsics1,
Stephen R. Wachtel1,
Sheldon Milstien2,
Kazuyuki Hatakeyama3,
Jill B. Becker4, and
Un Jung Kang1
1 Departments of Neurology, Pharmacological and
Physiological Sciences, and Committee on Neurobiology, The University
of Chicago, Chicago, Illinois 60637, 2 Laboratory of Cell
Biology, National Institute of Mental Health, Bethesda, Maryland
20892-4096, 3 Department of Surgery, University of
Pittsburgh, Pittsburgh, Pennsylvania 15261, and
4 Department of Biopsychology, University of Michigan, Ann
Arbor, Michigan 48104
Gene transfer of tyrosine hydroxylase (TH) in animal models of
Parkinson's disease (PD), using either genetically modified cells or
recombinant virus vectors, has produced partial restoration of
behavioral and biochemical deficits. The limited success of this
approach may be related to the availability of the cofactor,
tetrahydrobiopterin (BH4), because neither the
dopamine-depleted striatum nor the cells used for gene transfer possess
a sufficient amount of BH4 to support TH
activity. To determine the role of BH4 in gene
therapy, fibroblast cells transduced with the gene for TH were
additionally modified with the gene for GTP cyclohydrolase I, an enzyme
critical for BH4 synthesis. In contrast to cells
transduced with only TH, doubly transduced fibroblasts spontaneously
produced both BH4 and
3,4-dihydroxy-L-phenylalanine. To examine further
the importance of GTP cyclohydrolase I in gene therapy for PD, in
vivo microdialysis was used to assess the biochemical changes in
the dopamine-denervated striatum containing grafts of genetically
modified fibroblasts. Only denervated striata grafted with fibroblasts
possessing both TH and GTP cyclohydrolase I genes displayed biochemical
restoration. However, no significant differences from controls were
observed in apomorphine-induced rotation. This is partly attributable
to a limited duration of gene expression in vivo. These
differences between fibroblasts transduced with TH alone and those
additionally modified with the GTP cyclohydrolase I gene indicate that
BH4 is critical for biochemical restoration in a
rat model of PD and that GTP cyclohydrolase I is sufficient for
production of BH4.
Key words:
tetrahydrobiopterin;
Parkinson's disease;
gene
therapy;
retrovirus vector;
transplantation;
catecholamine
This article has been cited by other articles:

|
 |

|
 |
 
T. Carlsson, C. Winkler, C. Burger, N. Muzyczka, R. J. Mandel, A. Cenci, A. Bjorklund, and D. Kirik
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors
Brain,
March 1, 2005;
128(3):
559 - 569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-R. Kweon, J. D. Marks, R. Krencik, E. H. Leung, P. T. Schumacker, K. Hyland, and U. J. Kang
Distinct Mechanisms of Neurodegeneration Induced by Chronic Complex I Inhibition in Dopaminergic and Non-dopaminergic Cells
J. Biol. Chem.,
December 10, 2004;
279(50):
51783 - 51792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Habecker, M. G. Klein, N. C. Sundgren, W. Li, and W. R. Woodward
Developmental Regulation of Neurotransmitter Phenotype through Tetrahydrobiopterin
J. Neurosci.,
November 1, 2002;
22(21):
9445 - 9452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kirik, B. Georgievska, C. Burger, C. Winkler, N. Muzyczka, R. J. Mandel, and A. Bjorklund
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
PNAS,
March 21, 2002;
(2002)
62047599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Corti, A. Sanchez-Capelo, P. Colin, N. Hanoun, M. Hamon, and J. Mallet
Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease
PNAS,
October 12, 1999;
96(21):
12120 - 12125.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Y. Lee, J. W. Chang, N. L. Nemeth, and U. J. Kang
Vesicular Monoamine Transporter-2 and Aromatic L-Amino Acid Decarboxylase Enhance Dopamine Delivery after L-3,4-Dihydroxyphenylalanine Administration in Parkinsonian Rats
J. Neurosci.,
April 15, 1999;
19(8):
3266 - 3274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Mandel, K. G. Rendahl, S. K. Spratt, R. O. Snyder, L. K. Cohen, and S. E. Leff
Characterization of Intrastriatal Recombinant Adeno-Associated Virus-Mediated Gene Transfer of Human Tyrosine Hydroxylase and Human GTP-Cyclohydrolase I in a Rat Model of Parkinson's Disease
J. Neurosci.,
June 1, 1998;
18(11):
4271 - 4284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakamura, V. P. Bindokas, D. Kowlessur, M. Elas, S. Milstien, J. D. Marks, H. J. Halpern, and U. J. Kang
Tetrahydrobiopterin Scavenges Superoxide in Dopaminergic Neurons
J. Biol. Chem.,
September 7, 2001;
276(37):
34402 - 34407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kirik, B. Georgievska, C. Burger, C. Winkler, N. Muzyczka, R. J. Mandel, and A. Bjorklund
Reversal of motor impairments in parkinsonian rats by continuous intrastriatal delivery of L-dopa using rAAV-mediated gene transfer
PNAS,
April 2, 2002;
99(7):
4708 - 4713.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|